Table 1.
Comparison of clinicopathological features between the recurrence group and non-recurrence group, n (%)
|
Groups
|
Recurrence group (n = 69)
|
Non-recurrence group (n = 41)
|
t value
|
P value
|
| Age (mean ± SD, yr) | 54.63 ± 15.58 | 55.10 ± 15.29 | ||
| Gender | 3.497 | 0.061 | ||
| Men | 40 (57.97) | 31 (75.61) | ||
| Female | 29 (42.03) | 10 (24.39) | ||
| HbsAg | 0.313 | 0.576 | ||
| Negative | 22 (31.88) | 11 (26.83) | ||
| Positive | 47 (68.12) | 30 (73.17) | ||
| TNM staging | 10.959 | 0.001 | ||
| Stage I-II | 28 (40.58) | 30 (73.17) | ||
| Stage III-IV | 41 (59.42) | 11 (26.83) | ||
| Tumor diameter | 0.979 | 0.323 | ||
| < 5 cm | 27 (39.13) | 20 (48.78) | ||
| ≥ 5 cm | 42 (60.87) | 21 (51.22) | ||
| Degree of tumor differentiation | 6.353 | 0.012 | ||
| Low differentiation | 30 (43.48) | 28 (68.29) | ||
| High differentiation | 39 (56.52) | 13 (31.71) | ||
| Lymph node metastasis | 5.208 | 0.022 | ||
| Yes | 30 (43.48) | 9 (21.95) | ||
| No | 39 (56.52) | 32 (78.05) | ||
| Number of tumors | 0.298 | 0.585 | ||
| Multiple | 44 (63.77) | 24 (58.54) | ||
| Single | 25 (36.23) | 17 (41.46) | ||
| Alpha-fetoprotein (μg/L) | 3.137 | 0.077 | ||
| < 200 | 37 (53.62) | 29 (70.73) | ||
| ≥ 200 | 32 (46.38) | 12 (29.27) |